Back to screener
Venmax Drugs And Pharmaceuticals Ltd
₹14.81
▲ 1.21 (+8.90%) today
Latest quote · Yahoo Finance
Market Cap
₹21 Cr
P/E (TTM)
61.7
P/B
1.2
Book Value
₹12.87
ROE
3.4%
Div Yield
—
D/E
0.01
EPS (TTM)
₹0.24
52W High
₹31.49
52W Low
₹12.71
Sales Growth
+104.90%
Profit Growth
+40.80%
Day High
₹14.90
Day Low
₹13.70
Volume
26,101
Fundamentals refreshed 7 hr ago · Statements just now · Source: Yahoo Finance
Quick Take
- • Trading at 61.7× trailing earnings
- • Moderate ROE at 3.4%
- • Low leverage (D/E 0.01)
- • No dividend data
- • Operating margin 4.7% · Net margin 3.5%
- • Profit growth +40.80% YoY · Beta -1.76
Employees: 2
Latest quarter · Jun 2026
| ₹ Cr | Jun 2026 | QoQ | YoY |
|---|---|---|---|
| Revenue | 2 | -50.00% | +100.00% |
| Operating Profit | 0 | — | — |
| Net Profit | 0 | — | — |
| EPS (₹) | 0.10 | -50.00% | +42.86% |
OPM 4.8% · Net margin 4.7% · prev quarter OPM 2.7%
Shareholding Pattern
Numbers in percentages · Source: Yahoo Finance
Promoters / Insiders59.90%
Public & Others40.10%
About the company
From latest AR & concall Reading the latest annual report and earnings call… (1–3 min on first visit)
Venmax Drugs and Pharmaceuticals Limited engages in the business of pharmaceutical products, drug intermediaries, and API's in India. The company was formerly known as Yenkey Drugs & Pharmaceuticals Ltd and changed its name to Venmax Drugs and Pharmaceuticals Limited in April 2009. Venmax Drugs and Pharmaceuticals Limited was incorporated in 1988 and is based in Hyderabad, India.
